Related Experiment Videos

The radial width of the temporal horn in mild cognitive impairment

Giovanni B Frisoni1, Roberta Rossi, Alberto Beltramello

  • 1Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio FBF-National Center for Research and Care of Alzheimer's Disease, via Pilastroni 4, 25125-Brescia, Italy. papers@centroalzheimer.it

Abstract

Insights

The radial width of the temporal horn (rWTH) shows high accuracy in detecting early Alzheimer's disease (AD) and mild cognitive impairment (MCI) using CT scans. This CT-based marker aids in diagnosing brain atrophy in preclinical AD.

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Diagnosing preclinical Alzheimer's disease (AD) and mild cognitive impairment (MCI) presents significant diagnostic challenges.
  • Medial temporal lobe atrophy is a key indicator of early AD.
  • Existing diagnostic methods for MCI and early AD carry a degree of uncertainty.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of a computed tomography (CT)-based marker.
  • To assess the radial width of the temporal horn (rWTH) as a measure of medial temporal lobe atrophy.
  • To determine the effectiveness of rWTH in identifying mild cognitive impairment (MCI).

Main Methods:

  • Brain CT scans were performed on 10 MCI patients, 42 AD patients, and 29 controls.
  • The radial width of the temporal horn (rWTH) was measured using a precision caliper on CT films.
  • Measurements were taken on the temporal lobe plane with a 2 mm slice thickness.

Main Results:

  • With 95% specificity, the rWTH detected AD in 93% of cases (39/42).
  • The sensitivity for detecting MCI using rWTH was 80% (8/10).
  • The rWTH demonstrated significant sensitivity to regional brain atrophy characteristic of early AD.

Conclusions:

  • The radial width of the temporal horn (rWTH) is a sensitive CT-based marker for detecting atrophy in early Alzheimer's disease.
  • rWTH shows promise as a tool for improving the diagnosis of mild cognitive impairment (MCI).
  • This imaging marker can aid in the uncertain diagnosis of preclinical AD.

Related Concept Videos